CagriSema: Combination Therapy Program CagriSema is a fixed-ratio combination of cagrilintide (amylin analogue) and semaglutide 2.4 mg (GLP-1 receptor agonist), designed to provide superior weight loss through complementary mechanisms of action
Recommended Stack Additions For enhanced results, consider adding: DHEA Supports hormonal balance and testosterone output ZMT Nighttime testosterone and recovery support with GABA, ashwagandha, and magnesium L-Glutamine Promotes gut health, immune resilience, and post-training recovery This combination not only amplifies the peptide stacks effects, but also supports overall endocrine health, muscle recovery, and deep sleepkey to optimizing performance naturally
GHK-Cu addresses follicle cell health, inflammation, and anagen extension
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 14 H 22 N 4 O 9 Weight: 390.34 g/mol CAS: 307297-39-8 Structure: Ala-Glu-Asp-Gly PHYSICAL PROPERTIES Form: White lyophilized powder Solubility: Readily dissolves in water Origin: Synthetic version of epithalamin Storage: Keep refrigerated 3646 F (28 C)